Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy

• Conditions: Peripheral Neuropathy

• Registration Number: NCT01524666
• Lead Sponsor: JFK Medical Center

Brief Summary

This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of Arginine) and monitored for two months. Improvement will be noted on their response to the Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by performing autonomic function testing at the beginning and end of the study.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-01-31
• Study Start: 2012-02
• Study First Submitted QC: 2012-02-01
• Study First Posted: 2012-02-02
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-27
• Last Update Posted: 2018-02-28
• Primary Completion: 2018-10
• Study Completion: 2018-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• Men and Women Ages 18-75 with symptoms of small Fiber Neuropathy and have been diagnosed via autonomic function testing and or skin biopsy

Read More

Exclusion Criteria

• Women who are pregnant or breast feeding, patients with history of substance abuse, and patients with myelopathy

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Neuropathic Pain Questionnaire	After 2 months

Secondary Outcome Measures

Name	Time	Method
QSART & ANSAR testing	After 2 months

Trial Locations

Locations (1)

JFK Medical Center; 🇺🇸 Edison, New Jersey, United States